Physician profile
Curt Stock
NPI 1275681686
$5,116.31
in general payments reported to CMS, 2019-2025
7 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,890 · 2020: $46.65 · 2021: $1,180.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optinose US, INC. | $3,837.25 | 2019 | |
| Globus Medical, INC. | $1,179.75 | 2021 | |
| Medtronic USA, INC. | $37.88 | 2019-2020 | |
| Acclarent, INC | $19.57 | 2019 | |
| Arbor Pharmaceuticals, INC. | $15.14 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $14.99 | 2020 | |
| Stryker Corporation | $11.73 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Curt Stock listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.